18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy

被引:0
作者
Sandra J. Rosenbaum-Krumme
Rainer Görges
Andreas Bockisch
Ina Binse
机构
[1] University Hospital Essen,Department of Nuclear Medicine
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词
High-risk thyroid carcinoma; FDG; Initial diagnostics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1373 / 1380
页数:7
相关论文
共 136 条
[1]  
Mazzaferri EL(2001)Current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 1447-1463
[2]  
Kloos RT(2007)Radioiodine in the treatment of thyroid cancer Endocrinol Metab Clin North Am 36 807-822
[3]  
Van Nostrand D(2006)Management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 16 109-142
[4]  
Wartofsky L(2006)European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 787-803
[5]  
Cooper DS(1998)The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma Cancer 82 375-388
[6]  
Doherty GM(1985)Long-term results and prognostic factors in patients with differentiated thyroid carcinoma Cancer 55 794-804
[7]  
Haugen BR(1994)Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 418-428
[8]  
Kloos RT(2005)Role of 131I in the treatment of well differentiated thyroid cancer J Surg Oncol 89 114-121
[9]  
Lee SL(2003)Is (18F)-2-fluoro-2-deoxy-D-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol 149 293-300
[10]  
Mandel SJ(1999)Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicenter study Eur J Nucl Med 26 1547-1552